Instil Bio, Inc.

Instil Bio (TIL) has logged zero cyber incidents and zero red-flag 8-K filings over the past 90 days, signaling a quiet period operationally and structurally. However, low signal in our window does not mean low risk; biotech firms face layered exposures that require deeper context. The full $49 Report extends analysis to 12 months of SEC filings, maps dilution risk scores, financing history, and AI-detected stress signals in officer language and clinical timelines. See the complete picture: dilution trajectory, capital burn runway, and early-stage clinical asset risk that shape long-term shareholder value.